Li, Shirong <br/><br/>
Elevated Translation Initiation Factor eIF4E Is an Attractive Therapeutic Target in Multiple Myeloma.  [electronic resource] 

 -  Molecular cancer therapeutics  04 2016 
 - 711-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1538-8514 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-15-0798  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Biomarkers<br/>CCAAT-Enhancer-Binding Protein-beta--genetics<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Disease Models, Animal<br/>Ectopic Gene Expression<br/>Eukaryotic Initiation Factor-4E--antagonists & inhibitors<br/>Female<br/>Gene Expression<br/>Gene Expression Regulation, Neoplastic<br/>Gene Knockdown Techniques<br/>Genes, myc<br/>Humans<br/>Interferon Regulatory Factors--genetics<br/>Mice<br/>Molecular Targeted Therapy<br/>Multiple Myeloma--drug therapy<br/>Neovascularization, Pathologic--drug therapy<br/>RNA Interference<br/>Signal Transduction--drug effects<br/>Stromal Cells--drug effects<br/>Tumor Burden--drug effects<br/>Xenograft Model Antitumor Assays